New Blood Tests Enhance Alzheimer's Diagnosis Accuracy

Innovative blood tests show 90% accuracy, outperforming traditional diagnostic methods and expediting treatment access.

Blood tests measuring biomarkers like phosphorylated tau can detect Alzheimer's with 90% accuracy.
These tests outperform traditional methods used by both primary care doctors and specialists.
Early diagnosis through blood tests can reduce wait times for treatment and clinical trial participation.
St. Louis-based C2N Diagnostics is a key player in developing these advanced tests.
Experts anticipate that widespread adoption of blood tests could transform Alzheimer's care and research.